Recently, China Academy of Sciences' Internet Weekly, Deben Consulting and China Academy of Social Sciences' Informatization Research Center's eNet Research Institute jointly released the list of "2023 Top 100 New Technologies in China". DHC made the list successfully with its strong scientific and technological innovation ability. Together with a number of listed companies in the medical and health field, it was named as "Life and Health" and placed fourth. 

In the Report to the 20th CPC National Congress, leaders pointed out that high-quality development is the primary task of building a socialist modern country in an all-round way, and accelerating the realization of high-level scientific and technological self-reliance is the only way to promote high-quality development. In recent years, China's rapid development of science and technology, has made significant progress in the field of scientific and technological innovation, is no longer just a follower, but become one of the leaders of global scientific and technological innovation.

Scientific and technological innovation is also changing rapidly in the field of health care. The deep combination of technologies such as artificial intelligence, big data, and precision medicine with health care has brought new breakthroughs and application innovations. As an enterprise dedicated to becoming an international leader in medical big data and artificial intelligence, DHC has given full play to its advantages, strengthened the deep integration of technology and industry, focused on developing the innovative applications of big data and artificial intelligence technology in the medical field, and provided advanced products and excellent solutions for the whole ecology of health care to enable the development of medical and health industry through scientific and technological innovation.

Since its establishment, with its independent innovation ability and rich experience, DHC has preempted the medical and health science and technology to a new high, actively explored and promoted the application value of innovative technologies in the medical field, and has been recognized by many parties. At present, more than 40 national scientific research projects and major national projects have been carried out in total. The data deposition and technical experience cover the specialized disease fields such as cancer, rare diseases, cardiovascular and cerebrovascular diseases, and kidney diseases, and they have participated in the construction of several national database platforms for specialized diseases. They have successfully applied for and successfully completed multiple national key research and development plans of the 13^th and 14^th Five-Year Plans, scientific and technological innovation 2030, 863 Plan and other national large-scale project projects, processed more than 400 million patient data, and more than 2,000 cooperative hospital customers, serving as the backbone supporting national technological innovation.

In September, 2023, DHC won the recognition of "Beijing Municipal Enterprise Technology Center", which reflects the Beijing municipal government's overall recognition of DHC innovation and development achievements in many aspects, such as innovation benefit, competitive advantage, technical level, research and development investment, intellectual property rights, etc. With the arrival of the big model era, DHC will rely on AI technology to drive industry innovation, realize AI strategic upgrade, build a leading domestic big model in the medical field, comprehensively lead the multi-modal big data medical AI industry, contribute to the national scientific and technological innovation in the medical and health field, and strive to bring more breakthrough progress to boost the high-quality development of the medical and health industry.